Search Results - "Słuszniak, J."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    EPR dosimetry for actual and suspected overexposures during radiotherapy treatments in Poland by Trompier, F., Sadlo, J., Michalik, J., Stachowicz, W., Mazal, A., Clairand, I., Rostkowska, J., Bulski, W., Kulakowski, A., Sluszniak, J., Gozdz, S., Wojcik, A.

    Published in Radiation measurements (01-07-2007)
    “…EPR dosimetry on bone samples was recently used for actual and suspected overexposures during radiotherapy treatments performed in Poland. In 2001 five…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs chemoradiation by Bujko, K., Nowacki, M. P., Kępka, L., Olędzki, J., Bębenek, M., Kryj, M.

    Published in Colorectal disease (01-07-2005)
    “…Objective  The primary outcome was sphincter preservation. No benefit was found with chemoradiation. The aim of this report is to analyse postoperative…”
    Get full text
    Journal Article
  4. 4

    Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast by Góźdź, S S, Kowalska, M M, Słuszniak, J T, Słuszniak, A, Korejba, W, Bukowski, J, Banasińska, E, al-Jazzaf, H, Szymendera, J J

    Published in Tumor biology (1989)
    “…Pretreatment serum concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen (MCA) were determined in 129 patients with…”
    Get more information
    Journal Article
  5. 5
  6. 6

    CA 19-9 and CA 125 antigens in the sera of patients with cancer of the large intestine in relation to its clinical progress by Bukowski, J, Góźdź, S, Słuszniak, J, Korejba, W, Zieliński, A

    Published in Wiadomości lekarskie (1960) (01-01-1989)
    “…By radioimmunoassay the concentration of the CA 19-9 antigen was determined in the serum of 68 patients with large bowel cancer, while the CA 125 antigen was…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15